16-71129790-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001270974.2(HYDIN):āc.1077T>Cā(p.Asp359Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.278 in 1,584,486 control chromosomes in the GnomAD database, including 31,086 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.29 ( 3298 hom., cov: 30)
Exomes š: 0.28 ( 27788 hom. )
Consequence
HYDIN
NM_001270974.2 synonymous
NM_001270974.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.70
Genes affected
HYDIN (HGNC:19368): (HYDIN axonemal central pair apparatus protein) This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 16-71129790-A-G is Benign according to our data. Variant chr16-71129790-A-G is described in ClinVar as [Benign]. Clinvar id is 402957.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.7 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.43 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HYDIN | NM_001270974.2 | c.1077T>C | p.Asp359Asp | synonymous_variant | 9/86 | ENST00000393567.7 | NP_001257903.1 | |
HYDIN | NM_017558.5 | c.1077T>C | p.Asp359Asp | synonymous_variant | 9/20 | NP_060028.2 | ||
HYDIN | NM_001198542.1 | c.1158T>C | p.Asp386Asp | synonymous_variant | 9/19 | NP_001185471.1 | ||
HYDIN | NM_001198543.1 | c.1128T>C | p.Asp376Asp | synonymous_variant | 9/19 | NP_001185472.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HYDIN | ENST00000393567.7 | c.1077T>C | p.Asp359Asp | synonymous_variant | 9/86 | 5 | NM_001270974.2 | ENSP00000377197.2 |
Frequencies
GnomAD3 genomes AF: 0.291 AC: 43443AN: 149160Hom.: 3287 Cov.: 30
GnomAD3 genomes
AF:
AC:
43443
AN:
149160
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.336 AC: 71275AN: 212204Hom.: 10052 AF XY: 0.329 AC XY: 37756AN XY: 114780
GnomAD3 exomes
AF:
AC:
71275
AN:
212204
Hom.:
AF XY:
AC XY:
37756
AN XY:
114780
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.277 AC: 397009AN: 1435208Hom.: 27788 Cov.: 33 AF XY: 0.278 AC XY: 198395AN XY: 714000
GnomAD4 exome
AF:
AC:
397009
AN:
1435208
Hom.:
Cov.:
33
AF XY:
AC XY:
198395
AN XY:
714000
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.291 AC: 43490AN: 149278Hom.: 3298 Cov.: 30 AF XY: 0.291 AC XY: 21226AN XY: 72862
GnomAD4 genome
AF:
AC:
43490
AN:
149278
Hom.:
Cov.:
30
AF XY:
AC XY:
21226
AN XY:
72862
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 02, 2021 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 28, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at